Rayvax Société d'Investissements SA
Rayvax Société d'Investissements reported total assets of €2.91m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Dec 2025).
The score of Rayvax Société d'Investissements shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -85 % Total assets -90 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rayvax Société d'Investissements's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 22 Dec 2025
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 15 Jan 2024
- Year ended 30 Jun 2022filed on 28 Dec 2022
- Year ended 30 Jun 2021filed on 26 Nov 2021
Rayvax Société d'Investissements's financial analysis
Management and control of Rayvax Société d'Investissements
5 active director(s) in the register.
Rayvax Société d'Investissements's shareholders and holdings →Rayvax Société d'Investissements's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0421.798.659
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0421798659 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Jun 1981
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 22 Dec 2025
Rayvax Société d'Investissements (SA) has been based in Ixelles since 1981, active in: —. For 2025, it reports a net profit of 88,831 € and equity of €2.90m; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rayvax Société d'Investissements
Companies in the same business, of comparable size and area, outside its group.
- Bafco Rental and operating of own or leased real estate Roosdaal · balance sheet €2.90m
- JCF Invest Activities of holding companies Jalhay · balance sheet €2.91m
- Wanzeele G Manufacture of other builders’ carpentry and joinery Oosterzele · balance sheet €2.90m
- International Food Regulatory Services Activities of holding companies Brussels · balance sheet €2.90m
- Immo Magic Buying and selling of own real estate Antwerp · balance sheet €2.90m
- Solana Rental and operating of own or leased real estate Antwerp · balance sheet €2.92m
- Hosmid Buying and selling of own real estate Ypres · balance sheet €2.90m
- Greisch Participations Liège · balance sheet €2.31m
Frequently asked questions about Rayvax Société d'Investissements
What is the revenue of Rayvax Société d'Investissements?
Rayvax Société d'Investissements files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rayvax Société d'Investissements?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Rayvax Société d'Investissements. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0421798659. Its company number (CBE) is 0421.798.659.
Where is the registered office of Rayvax Société d'Investissements?
According to the CBE register, the registered office of Rayvax Société d'Investissements is in 1050 Ixelles.
What is the equity of Rayvax Société d'Investissements?
At the close of the 2025 financial year, the equity of Rayvax Société d'Investissements amounts to 2,900,423 €, a solvency of 99.8% of total assets.
Who manages Rayvax Société d'Investissements?
The register lists 5 active mandates at Rayvax Société d'Investissements. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rayvax Société d'Investissements
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →